Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.58 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.46 |
| ▸ | TGM2 | P21980 | 10/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11694993 | 0.98 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR | |
| SCHEMBL29161807 | 0.98 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR | |
| SCHEMBL5050870 | 0.98 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR | |
| SCHEMBL4807878 | 0.98 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR | |
| SCHEMBL9625870 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR | |
| SCHEMBL11695495 | 0.98 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR | |
| SCHEMBL462110 | 0.98 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR | |
| SCHEMBL2785000 | 0.98 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR | |
| SCHEMBL27760620 | 0.98 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR | |
| SCHEMBL25112 | 0.96 | ZDHHC20 (0.58) | ZDHHC20ZDHHC2MAPK1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1471 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618000-B2 | Friction reduction of acidic treatment fluids | HALLIBURTON ENERGY SERVICES, INC. (US) | 2026-05-05 | — | — | US | claimed |
| EP-3746533-B1 | LIQUID FABRIC ENHANCERS COMPRISING BRANCHED POLYESTER MOLECULES | PROCTER & GAMBLE (US) | 2025-11-05 | — | — | EP | claimed |
| EP-3623527-B1 | FABRIC CARE COMPOSITION COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | PROCTER & GAMBLE (US) | 2025-10-08 | — | — | EP | claimed |
| EP-3802661-B1 | LIQUID FABRIC ENHANCERS COMPRISING BRANCHED POLYESTER MOLECULES | PROCTER & GAMBLE (US) | 2025-09-10 | — | — | EP | claimed |
| US-20250277069-A1 | VINYL ESTER LATEX | ROHM AND HAAS COMPANY | 2025-09-04 | — | — | US | claimed |
| CN-120127239-A | Hydrogel electrolyte, preparation method thereof and zinc ion battery | 维特新能(广东)科技有限公司 | 2025-06-10 | — | — | CN | claimed |
| US-20250051635-A1 | FRICTION REDUCTION OF ACIDIC TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-02-13 | — | — | US | claimed |
| EP-3347446-B1 | A STABLE LAUNDRY OR CLEANING COMPOSITION, PROCESS FOR PREPARING THE SAME, AND METHOD OF USE | ISP INVESTMENTS LLC (US) | 2024-12-11 | — | — | EP | claimed |
| US-12139667-B1 | Friction reduction of acidic treatment fluids | HALLIBURTON ENERGY SERVICES, INC. (US) | 2024-11-12 | — | — | US | claimed |
| US-20230285630-A1 | PLASMA HYDROGEL THERAPY | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2023-09-14 | — | — | US | claimed |
| US-6149900-A | THE OUTER AQUEOUS PHASE COMPRISING AN EMULSIFYING COPOLYMER OF CARBOXYLIC ACID WITH A FATTY CHAIN, AND A CROSSLINKED POLYACRYLAMIDOMETHYLPROPANE-SULFONIC ACID; FOR CLEANING, PROTECTING THE SKIN, MUCOUS MEMBRANES AND HAIR | L'OREAL S.A. (FR) | 2000-11-21 | — | — | US | claimed |
| WO-2000064533-A1 | METHODS AND DEVICES FOR REMOVING INTERFERING SPECIES | CYGNUS, INC. (US) | 2000-11-02 | — | — | WO | claimed |
| EP-0908170-B1 | Stable water-in-oil-in-water emulsion and its use as cosmetic and/or dermatological composition | OREAL (FR) | 2000-05-31 | — | — | EP | claimed |
| EP-0934077-A2 | POLYANIONIC POLYMERS AS ADJUVANTS FOR MUCOSAL IMMUNIZATION | DIMMINACO AG/SA/LTD. (CH) | 1999-08-11 | — | — | EP | claimed |
| US-5812300-A | Electrochromic materials and displays | MONSANTO COMPANY (US) | 1998-09-22 | — | — | US | claimed |
| EP-0840597-A1 | HYDROGEL PATCH | CYGNUS, INC. (US) | 1998-05-13 | — | — | EP | claimed |
| WO-1998017310-A2 | POLYANIONIC POLYMERS AS ADJUVANTS FOR MUCOSAL IMMUNIZATION | DIMMINACO AG/S.A./LTD. (CH) | 1998-04-30 | — | — | WO | claimed |
| WO-1997002811-A1 | HYDROGEL PATCH | CYGNUS, INC. (US) | 1997-01-30 | — | — | WO | claimed |
| US-5378402-A | Electroconductive polymers and dopes | RAYCHEM LIMITED (GB) | 1995-01-03 | — | — | US | claimed |
| US-4552927-A | POLYMERIC ANION | ROCKWELL INTERNATIONAL CORPORATION (US) | 1985-11-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618000-B2 | Friction reduction of acidic treatment fluids | GFER, FGB, NSF | ZDHHC20 4132/4885ZDHHC2 4203/4885MAPK1 595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.